Lack of association between schizophrenia and the apolipoprotein E ε4 allele

  • E. Jönsson
  • G. Sedvall
  • L. Lannfelt
  • B. Engvall
Original Paper

Abstract

The association between the ε4 allele of the apolipoprotein E (APOE) gene and Alzheimer's disease (AD) has been reported. In order to examine if the ε4 allele may play a role also in schizophrenia, another mental disorder, patients (n=87) and control subjects (n=57) were genotyped for APOE. No significant difference was found between the groups. The data indicate that the APOE gene is not of major importance for the genesis of schizophrenia.

Key words

Schizophrenia Apolipoprotein E Association study Psychiatric genetics Alzheimer's disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aksenova MV, Burbaeva GS, Kandror KV, Kapkov DV, Stepanov AS (1991) The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients. FEBS Lett 279:55–57Google Scholar
  2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R); 3rd edn; revised. American Psychiatric Press, Washington DCGoogle Scholar
  3. Amouyel P, Vidal O, Launay JM, Laplanche JL (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344:1315–1318Google Scholar
  4. Arnold SE, Franz BR, Trojanowski JQ (1994) Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 15:299–303Google Scholar
  5. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E association with astrocytic glia of the central nervous system and with non-myelinating glia of the peripheral nervous system. J Clin Invest 82:1501–1513Google Scholar
  6. Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE (1993) A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Res 49:41–62Google Scholar
  7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921–923Google Scholar
  8. Davidson M, Haroutunian V (1995) Cognitive impairment in geriatric schizophrenic patients. Clinical and postmortem characterization. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1447–1459Google Scholar
  9. El-Mallakh RS, Kirch DG, Shelton R, Fan KJ, Pezeshkpour G, Kanhouwa S, Wyatt RJ, Kleinman JE (1991) The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia. J Neuropsychiatry Clin Neurosci 3:383–386Google Scholar
  10. Gabriel SM, Bierer LM, Davidson M, Purohit DP, Perl DP, Haroutunian V (1994) Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease. J Neurochem 62:1516–1523Google Scholar
  11. Geijer T, Jönsson E, Neiman J (1995) Comment to “Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal”. Eur Arch Psychiatry Clin Neurosci 245: 53–54Google Scholar
  12. Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, Valverius P, Terenius L (1994) Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244:26–32Google Scholar
  13. Goldsmith SK, Joyce JN (1995) Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry 37:122–126Google Scholar
  14. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL (1994) Cortical cholinergic markers in schizophrenia. Schizophr Res 12:137–144Google Scholar
  15. Harrison PJ (1995) On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4:1–12Google Scholar
  16. Heaton R, Paulsen JS, McAdams LA, Kuck J, Zisook S, Braff D, Harris J, Jeste DV (1994) Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry 51:469–476Google Scholar
  17. Johnson G, Brane D, Block W, Kammen DP van, Gurklis J, Peters JL, Wyatt RJ, Kirck DG, Ghanbari HA, Merril CR (1992) Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl Theor Electrophor 3: 47–53Google Scholar
  18. Joober R, Rouleau G, Fon E, Lal S, Palmour R, Bloom D, Labelle A, Benkelfat C (1995) Apolipoprotein allelic variation in schizophrenia. Psychiatr Genet 5:S56Google Scholar
  19. Jönsson E, Forsell C, Lannfelt L, Sedvall G (1995) Schizophrenia and APP gene mutations. Biol Psychiatry 37:135–136Google Scholar
  20. Jönsson E, Lannfelt L, Sokoloff P, Schwartz J-C, Sedvall G (1993) Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr Scand 87:345–349Google Scholar
  21. Kendler KS, Diehl SR (1993) The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 19:261–285Google Scholar
  22. Kendler KS, Neale MC, Walsh D (1995) Evaluating the spectrum concept of schizophrenia in the Roscommon family study. Am J Psychiatry 152:749–754Google Scholar
  23. Kounnas MZ, Moir RD, Rebeck GW, Bush AL, Argraves WS, Tanzi RE, Hyman BT, Strickland DK (1995) LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82:331–340Google Scholar
  24. Kraepelin E (1919) Dementia praecox and paraphrenia (Facsimile edn.). Krieger, Huntington, NYGoogle Scholar
  25. Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L Eggertsen G, Berglund L, Angelin B, Linder J Winblad B, Basun H (1994) Lack of association between apolipoprotein E allele ε4 and sporadic Alzheimer's disease. Neurosci Lett 169:175–178Google Scholar
  26. Liu L, Forsell C, Lilius L, Axelman K, Corder EH, Lannfelt L (1996) Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families. Am J Med Genet (in press)Google Scholar
  27. Mant R, Asherson P, Gill M, McGuffin P, Owen M (1992) Schizophrenia scepticism. Nature Genet 2:12Google Scholar
  28. Poirer J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697–699Google Scholar
  29. Prohovnik I, Dwork AJ, Kaufman MA, Willson N (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 19:805–816Google Scholar
  30. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, McCrystal J, Losonczy M, Davis KL (1993) Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 33:255–260Google Scholar
  31. Sarter M (1994) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: to sides of the same coin? Psychopharmacology 114:539–550Google Scholar
  32. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Albert MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467–1472Google Scholar
  33. Shinitzky M, Deckmann M, Kessler A, Sirota P, Rabbs A, Elizur A (1991) Platelet autoantibodies in dementia and schizophrenia. Possible implication for mental disorders. Ann N Y Acad Sci 621:205–217Google Scholar
  34. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977–1981Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • E. Jönsson
    • 1
  • G. Sedvall
    • 1
  • L. Lannfelt
    • 2
  • B. Engvall
    • 2
  1. 1.Department of Clinical Neuroscience, Psychiatry SectionKarolinska InstituteStockholmSweden
  2. 2.Department of Geriatric MedicineHuddinge HospitalHuddingeSweden

Personalised recommendations